Chris@NNW, Author at NetworkNewsWire

WednesdayMar 01, 2017 2:15 pm

CytoDyn Inc.’s (CYDY) PRO 140 is One of the Most Promising Monoclonal Antibody Therapies

New forms of treatment based on monoclonal antibodies show a lot of promise for human immunodeficiency virus patients with drug resistance or limited treatment options, according to HIV/AIDS researchers at this year’s edition of the Conference on Retroviruses and Opportunistic Infections (CROI 2017), which was held last month in Seattle (http://nnw.fm/Co5Ma). Researchers focused on two monoclonal antibody therapies – PRO 140 from CytoDyn Inc. (OTCQB: CYDY) and Ibalizumab from TaiMed Biologics, both of which have shown impressive results during clinical trials as long-acting therapies for HIV patients with limited options because of HIV drug resistance. PRO 140 is currently in two…

WednesdayMar 01, 2017 1:16 pm

National Waste Management Holdings, Inc. (NWMH) is Increasing Shareholder Value with Roll-Up Strategy

With over 40 years of relevant industry experience, National Waste Management Holdings, Inc. (OTC: NWMH) is on a roll. The company continues to execute a roll-up strategy that is paying huge dividends. Since 2014, NWMH has executed five M&A transactions, which have resulted in an increased customer base, a wider menu of services and a bigger top line. Now, the company is focused on increasing shareholder value by squeezing synergies from those acquisitions. NWMH’s roll-up strategy took off on June 16, 2014, after a reverse merger with Sand/Land of Florida Enterprises, Inc. (“Sandland”), which then became a wholly-owned subsidiary of…